Date
- 2024 (56)
- 2023 (39)
- 2022 (37)
- 2021 (40)
- 2020 (30)
- 2019 (7)
- 2018 (6)
- 2017 (11)
- 2016 (14)
- 2015 (10)
- 2014 (16)
- 2013 (7)
- 2012 (5)
- 2011 (16)
- 2010 (10)
- 2009 (7)
- 2008 (6)
- 2007 (10)
- 2006 (15)
- 2005 (14)
- 2004 (13)
- 2003 (19)
- 2002 (19)
- 2001 (6)
- 2000 (14)
- 1999 (6)
- 1998 (19)
- 1997 (13)
- 1996 (27)
- 1995 (25)
- 1994 (22)
- 1993 (15)
- 1992 (13)
- 1991 (138)
Results for
"[search-keyword]"
Sponsor content
705 result(s) found, displaying 51 to 60
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CEFINTRA cefuroxime (as sodium) 50 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMIGRAN MIGRAINE LACTOSE FREE sumatriptan 50 mg (as succinate) tablet blister pack.